| Agenus Inc. AGEN | $18.38B | 150.95 | 31.7M | 0% | +$0 | 84.33 | |
| Verona Pharma plc VRNA | $51.29M | 31.45 | 3.19M | 0% | +$0 | 0.24 | |
| Nektar Therapeutics NKTR | $17.19M | 10.02 | 18.4M | 0% | +$0 | 0.08 | |
| Travere Therapeutics, Inc. TVTX | $56.82M | 9.68 | 7.37M | 0% | +$0 | 0.26 | |
| Pliant Therapeutics, Inc. PLRX | $85.67M | 9.53 | 5.75M | 0% | +$0 | 0.39 | |
| Terns Pharmaceuticals, Inc. TERN | $40.02M | 9.43 | 6.1M | 0% | +$0 | 0.18 | |
Mind Medicine (MindMed) Inc. MNMD | $62.67M | 9.28 | 6.67M | New | +$62.67M | 0.29 | |
Invivyd, Inc. IVVD | $48.64M | 9.18 | 10.95M | New | +$48.64M | 0.22 | |
| Ocular Therapeutix, Inc. OCUL | $115.77M | 8.21 | 12.72M | +37.82% | +$31.77M | 0.53 | |
| Bicycle Therapeutics plc BCYC | $86.91M | 8.16 | 3.49M | 0% | +$0 | 0.4 | |
Cybin Inc. CYBN | $24.04M | 7.82 | 58.14M | New | +$24.04M | 0.11 | |
| Pyxis Oncology, Inc. PYXS | $17.82M | 7.11 | 4.18M | New | +$17.82M | 0.08 | |
| Dynavax Technologies Corporation DVAX | $113.45M | 6.98 | 9.14M | +28.88% | +$25.42M | 0.52 | |
| Editas Medicine, Inc. EDIT | $41.01M | 6.72 | 5.53M | +0.99% | +$402,193.68 | 0.19 | |
| Repare Therapeutics Inc. RPTX | $12.64M | 6.32 | 2.68M | -10.3% | -$1.45M | 0.06 | |
Tourmaline Bio, Inc. TRML | $36.53M | 6.22 | 1.6M | -12.14% | -$5.05M | 0.17 | |
| 4D Molecular Therapeutics, Inc. FDMT | $96.68M | 5.87 | 3.03M | +32.84% | +$23.9M | 0.44 | |
| Olema Pharmaceuticals, Inc. OLMA | $36.51M | 5.77 | 3.23M | +67.04% | +$14.65M | 0.17 | |
Autolus Therapeutics plc AUTL | $97.44M | 5.74 | 15.27M | +28.67% | +$21.71M | 0.45 | |
| Viridian Therapeutics, Inc. VRDN | $60.52M | 5.42 | 3.46M | -4.84% | -$3.08M | 0.28 | |
| HilleVax, Inc. HLVX | $42.78M | 5.17 | 2.57M | -11.29% | -$5.45M | 0.2 | |
| Geron Corporation GERN | $100.67M | 5.14 | 30.51M | +3.12% | +$3.04M | 0.46 | |
| Nurix Therapeutics, Inc. NRIX | $44.07M | 5.06 | 3M | 0% | +$0 | 0.2 | |
| Guardant Health, Inc. GH | $123.78M | 4.9 | 6M | +20% | +$20.63M | 0.57 | |
| Fate Therapeutics, Inc. FATE | $40.9M | 4.89 | 5.57M | New | +$40.9M | 0.19 | |
SpringWorks Therapeutics, Inc. SWTX | $171.28M | 4.7 | 3.48M | -14.37% | -$28.74M | 0.79 | |
Dyne Therapeutics, Inc. DYN | $129.33M | 4.67 | 4.56M | +127.77% | +$72.55M | 0.59 | |
| Intellia Therapeutics, Inc. NTLA | $115.84M | 4.37 | 4.21M | +87.15% | +$53.94M | 0.53 | |
Apogee Therapeutics, Inc. APGE | $154.39M | 3.98 | 2.32M | 0% | +$0 | 0.71 | |
| ANI Pharmaceuticals, Inc. ANIP | $56.82M | 3.92 | 822,001 | +37% | +$15.35M | 0.26 | |
| Alector, Inc. ALEC | $22.69M | 3.91 | 3.77M | New | +$22.69M | 0.1 | |
Silence Therapeutics plc SLN | $35.51M | 3.52 | 1.64M | -15.77% | -$6.65M | 0.16 | |
| Insmed Incorporated INSM | $129.78M | 3.22 | 4.78M | -10.59% | -$15.36M | 0.6 | |
Spyre Therapeutics, Inc. SYRE | $46.03M | 3.01 | 1.21M | -37.86% | -$28.04M | 0.21 | |
| Axsome Therapeutics, Inc. AXSM | $104.12M | 2.75 | 1.3M | +30.47% | +$24.32M | 0.48 | |
| Pacific Biosciences of California, Inc. PACB | $26.25M | 2.57 | 7M | 0% | +$0 | 0.12 | |
| Alkermes plc ALKS | $94.75M | 2.07 | 3.5M | -12.5% | -$13.54M | 0.44 | |
| Kymera Therapeutics, Inc. KYMR | $50.74M | 2.06 | 1.26M | New | +$50.74M | 0.23 | |
| AnaptysBio, Inc. ANAB | $11.92M | 1.94 | 529,452 | -74.01% | -$33.95M | 0.06 | |
| Intra-Cellular Therapies, Inc. ITCI | $103.8M | 1.42 | 1.5M | -25% | -$34.6M | 0.48 | |
| Ionis Pharmaceuticals, Inc. IONS | $59.54M | 0.94 | 1.37M | +9.96% | +$5.39M | 0.27 | |
| Scholar Rock Holding Corporation SRRK | $12.08M | 0.85 | 680,000 | -32.8% | -$5.89M | 0.06 | |
| Apellis Pharmaceuticals, Inc. APLS | $58.78M | 0.82 | 1M | New | +$58.78M | 0.27 | |
| Alnylam Pharmaceuticals, Inc. ALNY | $124.39M | 0.66 | 832,310 | New | +$124.39M | 0.57 | |
Neumora Therapeutics, Inc. Common Stock NMRA | $13.75M | 0.63 | 1M | New | +$13.75M | 0.06 | |
argenx SE ARGX | $118.12M | 0.51 | 300,000 | 0% | +$0 | 0.54 | |
| Nuvalent, Inc. NUVL | $20.61M | 0.43 | 274,512 | -39% | -$13.18M | 0.1 | |
| Immunovant, Inc. IMVT | $15.94M | 0.34 | 493,352 | -50.66% | -$16.37M | 0.07 | |
| Amgen Inc. AMGN | $156.38M | 0.1 | 550,000 | New | +$156.38M | 0.72 | |
Abivax SA American Depositary Shares ABVX | $61.45M | <0.01 | 4.3M | 0% | +$0 | 0.28 |